Back to Search Start Over

Adiposity, metabolites, and colorectal cancer risk : Mendelian randomization study

Authors :
Bull, Caroline J.
Bell, Joshua A.
Murphy, Neil
Sanderson, Eleanor
Davey Smith, George
Timpson, Nicholas J.
Banbury, Barbara L.
Albanes, Demetrius
Berndt, Sonja I.
Bezieau, Stephane
Bishop, D. Timothy
Brenner, Hermann
Buchanan, Daniel D.
Burnett-Hartman, Andrea
Casey, Graham
Castellvi-Bel, Sergi
Chan, Andrew T.
Chang-Claude, Jenny
Cross, Amanda J.
de la Chapelle, Albert
Figueiredo, Jane C.
Gallinger, Steven J.
Gapstur, Susan M.
Giles, Graham G.
Gruber, Stephen B.
Gsur, Andrea
Hampe, Jochen
Hampel, Heather
Harrison, Tabitha A.
Hoffmeister, Michael
Hsu, Li
Huang, Wen-Yi
Huyghe, Jeroen R.
Jenkins, Mark A.
Joshu, Corinne E.
Keku, Temitope O.
Kuhn, Tilman
Kweon, Sun-Seog
Le Marchand, Loic
Li, Christopher I.
Li, Li
Lindblom, Annika
Martin, Vicente
May, Anne M.
Milne, Roger L.
Moreno, Victor
Newcomb, Polly A.
Offit, Kenneth
Ogino, Shuji
Phipps, Amanda I.
Platz, Elizabeth A.
Potter, John D.
Qu, Conghui
Quiros, J. Ramon
Rennert, Gad
Riboli, Elio
Sakoda, Lori C.
Schafmayer, Clemens
Schoen, Robert E.
Slattery, Martha L.
Tangen, Catherine M.
Tsilidis, Kostas K.
Ulrich, Cornelia M.
van Duijnhoven, Franzel J. B.
van Guelpen, Bethany
Visvanathan, Kala
Vodicka, Pavel
Vodickova, Ludmila
Wang, Hansong
White, Emily
Wolk, Alicja
Woods, Michael O.
Wu, Anna H.
Campbell, Peter T.
Zheng, Wei
Peters, Ulrike
Vincent, Emma E.
Gunter, Marc J.
Bull, Caroline J.
Bell, Joshua A.
Murphy, Neil
Sanderson, Eleanor
Davey Smith, George
Timpson, Nicholas J.
Banbury, Barbara L.
Albanes, Demetrius
Berndt, Sonja I.
Bezieau, Stephane
Bishop, D. Timothy
Brenner, Hermann
Buchanan, Daniel D.
Burnett-Hartman, Andrea
Casey, Graham
Castellvi-Bel, Sergi
Chan, Andrew T.
Chang-Claude, Jenny
Cross, Amanda J.
de la Chapelle, Albert
Figueiredo, Jane C.
Gallinger, Steven J.
Gapstur, Susan M.
Giles, Graham G.
Gruber, Stephen B.
Gsur, Andrea
Hampe, Jochen
Hampel, Heather
Harrison, Tabitha A.
Hoffmeister, Michael
Hsu, Li
Huang, Wen-Yi
Huyghe, Jeroen R.
Jenkins, Mark A.
Joshu, Corinne E.
Keku, Temitope O.
Kuhn, Tilman
Kweon, Sun-Seog
Le Marchand, Loic
Li, Christopher I.
Li, Li
Lindblom, Annika
Martin, Vicente
May, Anne M.
Milne, Roger L.
Moreno, Victor
Newcomb, Polly A.
Offit, Kenneth
Ogino, Shuji
Phipps, Amanda I.
Platz, Elizabeth A.
Potter, John D.
Qu, Conghui
Quiros, J. Ramon
Rennert, Gad
Riboli, Elio
Sakoda, Lori C.
Schafmayer, Clemens
Schoen, Robert E.
Slattery, Martha L.
Tangen, Catherine M.
Tsilidis, Kostas K.
Ulrich, Cornelia M.
van Duijnhoven, Franzel J. B.
van Guelpen, Bethany
Visvanathan, Kala
Vodicka, Pavel
Vodickova, Ludmila
Wang, Hansong
White, Emily
Wolk, Alicja
Woods, Michael O.
Wu, Anna H.
Campbell, Peter T.
Zheng, Wei
Peters, Ulrike
Vincent, Emma E.
Gunter, Marc J.
Publication Year :
2020

Abstract

Background Higher adiposity increases the risk of colorectal cancer (CRC), but whether this relationship varies by anatomical sub-site or by sex is unclear. Further, the metabolic alterations mediating the effects of adiposity on CRC are not fully understood. Methods We examined sex- and site-specific associations of adiposity with CRC risk and whether adiposity-associated metabolites explain the associations of adiposity with CRC. Genetic variants from genome-wide association studies of body mass index (BMI) and waist-to-hip ratio (WHR, unadjusted for BMI; N = 806,810), and 123 metabolites from targeted nuclear magnetic resonance metabolomics (N = 24,925), were used as instruments. Sex-combined and sex-specific Mendelian randomization (MR) was conducted for BMI and WHR with CRC risk (58,221 cases and 67,694 controls in the Genetics and Epidemiology of Colorectal Cancer Consortium, Colorectal Cancer Transdisciplinary Study, and Colon Cancer Family Registry). Sex-combined MR was conducted for BMI and WHR with metabolites, for metabolites with CRC, and for BMI and WHR with CRC adjusted for metabolite classes in multivariable models. Results In sex-specific MR analyses, higher BMI (per 4.2 kg/m(2)) was associated with 1.23 (95% confidence interval (CI) = 1.08, 1.38) times higher CRC odds among men (inverse-variance-weighted (IVW) model); among women, higher BMI (per 5.2 kg/m(2)) was associated with 1.09 (95% CI = 0.97, 1.22) times higher CRC odds. WHR (per 0.07 higher) was more strongly associated with CRC risk among women (IVW OR = 1.25, 95% CI = 1.08, 1.43) than men (IVW OR = 1.05, 95% CI = 0.81, 1.36). BMI or WHR was associated with 104/123 metabolites at false discovery rate-corrected P <= 0.05; several metabolites were associated with CRC, but not in directions that were consistent with the mediation of positive adiposity-CRC relations. In multivariable MR analyses, associations of BMI and WHR with CRC were not attenuated following adjustment for representative

Details

Database :
OAIster
Notes :
application/pdf, English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1233756676
Document Type :
Electronic Resource
Full Text :
https://doi.org/10.1186.s12916-020-01855-9